Allergan CEO David Pyott talks Botox, medical devices and the aesthetics industry in this podcast, recorded at the MassDevice Big 100 West.
Three months before he took the reins at Boston Scientific, Mike Mahoney told MassDevice his thoughts on how he looked to turnaround the medical device giant in this podcast from the MassDevice Big 100 East
Sanovas' new MicroCam plug-and-play endoscopic imaging system paves the way for a paradigm shift toward linear medical devices for natural orifice surgery, CEO Larry Gerrans tells MassDevice.com.
In talking about his company's newly launched MicroCam laparoscopic imaging platform, Sanovas CEO Larry Gerrans tells a story of innovation and, perhaps more importantly, of evolution.
In an interview with MassDevice.com, Gerrans described the "plug-&-play...
A quartet of healthcare giants including UnitedHealth, the largest single health insurer in the U.S., joins forces for the SharedClarity project, aiming to leverage their combined Big Data to get the best devices for the best prices.
MassDevice talks disruptive business models in the medical device and hospital world with Novation executive and aptitude vice president Troy Kirchenbauer
Two years ago, Troy Kirchenbauer got an opportunity most employees would shy away from – the chance to put his company out of business.
The former Novation executive and current general manager of Aptitude LLC, a new web portal spunout of the Irving, TX.-based group purchasing organization, was tasked with leading a team with the mission of tearing apart not only Novation's business model, but the method by which hospitals buy billions of dollars of medical equipment...
Biomet CEO Jeff Binder tells MassDevice.com why gain sharing is bad for the medical device business and how the best is yet to come for the orthopedics sector.
Two decades after he jumped ship from the Boston Consulting Group into the orthopedic world, the business of bones and joints still fascinates Jeff Binder, despite some of the headwinds the industry has faced over the past 5 years.
Maybe that's because the CEO of Warsaw, Ind.-based Biomet, a privately held orthopedic medical device company, is experienced enough to know the industry has been counted out before.